You are here: Industry Insights > COVID-19 vaccine

News List

More than 78 lakh COVID vaccine doses still available with states and UTs: Centre expresspharma
May 06, 2021
Implementation of the Liberalised and Accelerated Phase 3 Strategy of COVID-19 vaccination started on Saturday, it informed.
MHRA reports 41 blood clot cases after use of AstraZeneca Covid-19 vaccine pharmaceutical-technology
May 06, 2021
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has reported an additional 41 cases of rare blood clots in people who have received doses of AstraZeneca’s Covid-19 vaccine.
Moderna receives emergency use listing from WHO for Covid-19 vaccine pharmaceutical-technology
May 06, 2021
Moderna has received emergency use listing (EUL) from the World Health Organization (WHO) for its Covid-19 vaccine to prevent the disease in individuals aged 18 years and above.
Pfizer, BioNTech seek CMA expansion for Covid-19 vaccine in EU pharmaceutical-technology
May 06, 2021
Pfizer and BioNTech have submitted a request to the European Medicines Agency (EMA) to expand Conditional Marketing Authorization (CMA) of their Covid-19 vaccine, COMIRNATY (BNT162b2), in the European Union (EU) for use in adolescents aged 12 to 15 years.
Vaxart’s Covid-19 vaccine shows cross-coronavirus activity in trial pharmaceutical-technology
May 06, 2021
Vaxart has reported the latest data from the Phase I trial of its first Covid-19 oral vaccine construct, VXA-CoV2-1, which showed broad cross-reactivity against other coronaviruses.
Moderna to supply Covid-19 vaccine doses to Gavi pharmaceutical-technology
May 06, 2021
Moderna has entered an agreement with Gavi, the Vaccine Alliance, to deliver up to 500 million doses of its mRNA Covid-19 vaccine to help low- and middle-income countries fight the pandemic.
Moderna to Increase Global Supply for COVID-19 Vaccine contractpharma
May 06, 2021
Moderna has unveiled plans for new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine, depending upon the ...
South Africa restarts inoculation with J&J’s Covid-19 vaccine pharmaceutical-technology
April 30, 2021
South Africa has resumed inoculation of health care workers with Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine after a pause of over two weeks due to rare blood clot reports.
Lonza Doubles Drug Substance Production for Moderna’s COVID-19 Vaccine contractpharma
April 30, 2021
Lonza has expanded its collaboration with Moderna to manufacture the drug substance for the biopharma’s COVID-19 vaccine.
Over a quarter of UK adults have received both COVID-19 vaccine doses pharmatimes
April 28, 2021
The Department of Health and Social Care (DHSC) has announced that over a quarter of adults in the UK have now received both doses of a COVID-19 vaccine in the latest vaccination milestone.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page